With the Federal Reserve under Kevin Warsh signaling less guidance on future interest rates and a potentially bumpier path for policy, many investors are rethinking how much volatility they want to tolerate. Low volatility stocks can sit in an interesting middle ground, offering exposure to the market while historically showing gentler price swings. This article looks at how the Fed’s communication reset might affect that type of positioning and reveals 3 stocks from a Low Volatility Stocks screener that appear more directly exposed to this news, so you can decide whether they deserve a closer look or a wider berth in your portfolio.

LeMaitre Vascular (LMAT)

Overview: LeMaitre Vascular develops, manufactures, and sells specialized medical devices and biologic implants used by vascular surgeons to treat diseased blood vessels and support cardiac and peripheral vascular procedures across the Americas, Europe, the Middle East, Africa, and Asia Pacific.

Operations: LeMaitre Vascular generates about US$256.3 million in revenue primarily from medical devices and implants for treating peripheral vascular disease, with the United States contributing US$144.1 million and additional sales from Canada, Germany, the United Kingdom, and other countries.

Market Cap: US$2.4b

Investors looking at low volatility ideas may find LeMaitre Vascular interesting because it sits in a healthcare niche where demand for vascular procedures tends to be steady. The company is still targeting higher 2026 revenue, earnings, and margin guidance. Earnings growth has recently been strong, supported by high gross margins and a focused product portfolio. However, that same reliance on niche devices and pricing leaves LeMaitre exposed if competitors or regulators push back. The valuation currently assumes a lot is going right, and recent insider selling and funding entirely from external borrowing add extra questions. For investors willing to do the work, the mix of quality fundamentals, moderate growth, and Fed driven rate volatility could make LeMaitre either a resilient holding or a crowded trade that needs a careful entry point.

LeMaitre Vascular’s strong margins and focused product mix could be masking a very different picture of risk and reward, and the full 2 key rewards and 1 important warning sign might highlight one twist in the story most investors are missing

Cochlear (ASX:COH)

Overview: Cochlear develops implantable hearing solutions for children and adults, including cochlear implants, bone conduction devices, and sound processor upgrades, aiming to restore hearing where traditional hearing aids are not enough.

Operations: Cochlear generates about A$2.3b in revenue primarily from implantable hearing devices.

Market Cap: A$8.4b

Cochlear gives low volatility investors exposure to a global hearing care leader in a sector where demand often holds up when economic policy is in flux. The company combines strong margins, premium products and an expanding installed base, but faces real pressure from slower system growth in some regions, pricing pressure in markets such as China, and a dividend that is not well covered by free cash flow. For investors weighing Fed driven rate uncertainty, the mix of resilient healthcare demand, moderate earnings growth and higher cost funding makes Cochlear an example of how some investors may think about “defensive” quality in a choppier rates regime.

Cochlear’s premium positioning and steady device demand hint at a story that may not fully match its current funding and dividend profile. The analysis report for Cochlear could reveal how those pieces really fit together.

Telecom Plus (LSE:TEP)

Overview: Telecom Plus provides UK households with a bundle of everyday essentials, reselling gas, electricity, broadband, mobile and fixed line phone services, plus insurance and cashback products under its Utility Warehouse and TML brands.

Operations: Telecom Plus generates about £1.9b in revenue from non regulated utility and related services, all from customers in the United Kingdom.

Market Cap: £612.3m

Telecom Plus stands out in a choppier Fed driven rates backdrop because its UK focused utility bundle can produce relatively steady cash flows while the stock trades well below some estimates of fair value. Revenue of about £1.9b and net income of £80.7m support a low P/E and high forecast ROE. However, the market is still weighing a sharply reduced dividend, high debt and reliance on external funding. The outcome of the reset payout, focus on EBITDA per customer and AI driven cost efficiencies will depend on how Telecom Plus handles competition, energy price swings and rising bad debts in the years ahead.

Telecom Plus looks like a low P/E, high cash flow story that the market has not fully re-rated yet, and the 4 key rewards and 4 important warning signs (1 is major!) could show whether those reduced dividends are masking something bigger or setting up a quiet reset investors have not priced in

The three low volatility stocks in this article are only a starting point, as the full Low Volatility Stocks screener surfaced 26 more companies with equally compelling, but very different, stories behind their steadier price histories. Use Simply Wall St to identify, compare and analyze the specific catalysts, balance sheet strength and dividend profiles that matter most to you so you can focus on the highest conviction ideas within this low volatility theme.

Take Control of Your Investment Journey

If Cochlear or any of these companies sound like a great opportunity, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value the ideal entry point. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond Low Volatility?

New opportunities do not wait. While attention sits on today’s low volatility stocks, other themes could be building quiet breakout momentum under the radar for now, so consider acting promptly.

• Target resilient cash generators by scanning a curated list of solid balance sheet and fundamentals (47 results) before the crowd focuses on their stronger fundamentals and quieter share price moves.
• Spot potential income workhorses with a hand picked set of 8 dividend fortresses before yields change or prices shift on renewed demand.
• Track infrastructure-related opportunities using a focused list of 35 power grid technology and infrastructure stocks while upgrade cycles may still be overlooked by many investors.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.